These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 26075455

  • 21. The effect of botulinum toxin a treatment on tear function parameters and on the ocular surface.
    Horwath-Winter J, Berglöff J, Flögel I, Haller-Schober EM, Müllner K, Schmut O.
    Adv Exp Med Biol; 2002; 506(Pt B):1241-6. PubMed ID: 12614060
    [No Abstract] [Full Text] [Related]

  • 22. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S, Susel Z, Honigman S.
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [Abstract] [Full Text] [Related]

  • 23. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Jul; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 24. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S, Kritalukkul S.
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [Abstract] [Full Text] [Related]

  • 25. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [Abstract] [Full Text] [Related]

  • 26. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F.
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
    Kocabeyoglu S, Sekeroglu HT, Mocan MC, Muz E, Irkec M, Sanac AS.
    Eur J Ophthalmol; 2014 Jan; 24(6):830-4. PubMed ID: 24803156
    [Abstract] [Full Text] [Related]

  • 31. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q.
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [Abstract] [Full Text] [Related]

  • 32. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K.
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [Abstract] [Full Text] [Related]

  • 33. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 34. Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB.
    Isshiki Y, Ishikawa H, Mimura O.
    Jpn J Ophthalmol; 2016 Nov; 60(6):486-491. PubMed ID: 27503401
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG, Pereira Lde S, da Cunha MC, Kitadai SP.
    Arq Bras Oftalmol; 2006 Nov; 69(5):701-5. PubMed ID: 17187139
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH, Kohl A.
    J Neurol; 2001 Apr; 248 Suppl 1():21-4. PubMed ID: 11357234
    [Abstract] [Full Text] [Related]

  • 39. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM, Carelli EF, Viana MA.
    Clin Neuropharmacol; 2010 Apr; 33(1):27-31. PubMed ID: 20124784
    [Abstract] [Full Text] [Related]

  • 40. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P, Choolam A, Kulkantrakorn K.
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.